SMTL ID : 3idp.2 (1 other biounit)

B-Raf V600E kinase domain in complex with an aminoisoquinoline inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x L1E: N~1~-(4-chlorophenyl)-6-methyl-N~5~-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine(Non-covalent)

L1E.1: 18 residues within 4Å: Chain A: V.44, A.54, V.55, K.56, E.74, V.77, L.78, L.87, I.100, T.102, Q.103, W.104, C.105, L.140, F.156, G.166, D.167, F.168 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:V.44, A:A.54, A:K.56, A:E.74, A:L.78, A:L.87, A:I.100, A:T.102 Hydrogen bonds: A:E.74, A:E.74, A:T.102, A:C.105, A:D.167 pi-Stacking: A:W.104, A:F.168, A:F.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Smith, A.L. et al., Selective inhibitors of the mutant B-raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline. J.Med.Chem. (2009)

Release Date

2009-10-06

Peptides

B-Raf proto-oncogene serine/threonine-protein kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B-Raf proto-oncogene serine/threonine-protein kinase

Related Entries With Identical Sequence